FDA Updates Blood Donation Regulations to Enhance Public Health

Summary

The Food and Drug Administration (FDA) has amended its biologics regulations to require blood and plasma establishments to notify donors about deferral or unsuitability for future donations, aiming to protect public health and promote industry consistency.